Immediate Impact

23 standout
Sub-graph 1 of 9

Citing Papers

Guidelines for accurate application of green and white analytical concepts: Merits Versus demerits with insights of significant milestones of assessment tools applied for antiviral drugs
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
7 intermediate papers

Works of Uwe Liebchen being referenced

Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum
2021
Unbound fraction of ertapenem in intensive care unit patients
2014

Author Peers

Author Last Decade Papers Cites
Uwe Liebchen 388 262 121 123 51 713
Christina Scharf 436 307 135 131 54 748
Arun Chopra 372 308 109 94 77 809
Jeffrey J. Cies 592 373 126 204 65 843
Janine Stuart 440 273 123 166 34 846
Pieter De Cock 422 255 121 69 61 801
Thierry Seguin 366 334 91 203 37 822
João Gonçalves-Pereira 404 420 83 184 66 811
Marie‐Clémence Verdier 287 230 195 107 83 820
Stefanie Swoboda 279 162 250 103 32 626
Martin G. Kees 431 193 130 140 36 699

All Works

Loading papers...

Rankless by CCL
2026